A 6-Week, Randomized Study to Evaluate the Potential of MC2-01 Cream to Induce Photoallergic Skin Reaction in Healthy Subjects, Using a Controlled Photopatch Test Design
Latest Information Update: 13 Mar 2020
At a glance
- Drugs Betamethasone-dipropionate/calcipotriol (Primary)
- Indications Plaque psoriasis; Psoriasis
- Focus Adverse reactions
- Sponsors MC2 Therapeutics
Most Recent Events
- 14 May 2019 Status changed from recruiting to completed.
- 05 Apr 2019 New trial record